INHBE and fibrodysplasia ossificans progressiva: Given that blocking activin signaling via the mutant ALK2R206H receptor has been shown to be an effective therapeutic approach to prevent HO in preclinical FOP models, we next investigated whether autophagy signaling may become a new therapeutic target in FOP.